Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 2/20 | 0.63 |
| ▸ | CPA3 | P15088 | 2/20 | 0.63 |
| ▸ | CPB1 | P15086 | 1/20 | 0.63 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.63 |
| ▸ | ACE | P12821 | 2/20 | 0.61 |
| ▸ | MME | P08473 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9554490 | 0.86 | CPA1 (0.60) | CPA1CPA3CPB1CPB2MME | |
| SCHEMBL9554486 | 0.86 | CPA1 (0.60) | CPA1CPA3CPB1CPB2MME | |
| SCHEMBL2807018 | 0.84 | MME (0.67) | CPA1CPA3CPB1CPB2ACE | |
| SCHEMBL7432078 | 0.82 | ACE (0.77) | ACEMMEMMEL1 | |
| SCHEMBL10396440 | 0.82 | ACE (0.77) | ACEMMEMMEL1 | |
| SCHEMBL7432071 | 0.82 | ACE (0.77) | ACEMMEMMEL1 | |
| SCHEMBL10396439 | 0.82 | ACE (0.77) | ACEMMEMMEL1 | |
| SCHEMBL7437961 | 0.82 | ACE (0.77) | ACEMMEMMEL1 | |
| SCHEMBL7431993 | 0.81 | ACE (0.75) | ACEMMEMMEL1 | |
| Succinic Acid SCHEMBL28290802 | 0.80 | CPA1 (0.89) | CPA1CPA3CPB1CPB2MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-11559474-B2 | Hair lightening compositions and methods of use | L'OREAL (FR) | 2023-01-24 | — | — | US | disclosed |
| WO-2018119500-A1 | VISCOELASTIC COSMETIC COMPOSITIONS | L'OREAL (FR) | 2018-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | CPA1 1954/4885CPA3 739/4885CPB1 2437/4885 |
| US-11559474-B2 | Hair lightening compositions and methods of use | TYR, ALAD, CYBA | CPA1 2310/4885CPA3 3285/4885CPB1 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.